All Stories

  1. Hyperglycaemic Metabolic Complications of Ischemic Brain: Current Therapeutics, Anti-Diabetics and Stem Cell Therapy
  2. Voglibose and saxagliptin ameliorate the post-surgical stress and cognitive dysfunction in chronic anaesthesia exposed diabetic MCAo induced ischemic rats
  3. Narcolepsy—A Neuropathological Obscure Sleep Disorder: A Narrative Review of Current Literature
  4. Seaweeds in the Oncology Arena: Anti-Cancer Potential of Fucoidan as a Drug—A Review
  5. Clinical and Radiological Characteristics for Recurrence of Chronic Subdural Hematoma: A Systematic Review and Meta-Analysis
  6. Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination
  7. PiWi RNA in Neurodevelopment and Neurodegenerative Disorders
  8. Molecular mechanisms of oxidative stress in stroke and cancer
  9. Bilateral Ovarian huge Benign Papillary Serous tumor in a teenage girl: A Case Report
  10. Neuronal Glial Crosstalk: Specific and Shared Mechanisms in Alzheimer’s Disease
  11. PCOS and Depression: Common Links and Potential Targets
  12. Cerebrovascular Complications of Diabetes: SGLT-2 Inhibitors as a Promising Future Therapeutics
  13. Chronic Kidney disease and stroke: A Bi-directional risk cascade and therapeutic update
  14. P-BN006. Post exposure of anti-diabetic agents exerts neuroprotection and improve memory and learning in endothelin-1 induced global ischemia in adult zebrafish
  15. Mini-review on SARS-CoV-2 infection and neurological manifestations: A Perspective
  16. The Multifarious Medical Applications of Carbon Curvatures: A Cohort review
  17. Recent Advances in Synaptosomal Proteomics in Alzheimer’s Disease
  18. Efonidipine Exerts Cerebroprotective Effect by Down-regulation of TGF-β/SMAD-2-Dependent Signaling Pathway in Diabetic Rats
  19. The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles
  20. CyberKnife for the management of Cushing’s disease: our institutional experience and review of literature
  21. Coding and non-coding nucleotides': The future of stroke gene therapeutics
  22. Stroke and Immunotherapy: Potential Mechanisms and its implications as immune‐therapeutics
  23. Functional Role of Novel Indomethacin Derivatives for the Treatment of Hepatocellular Carcinoma Through Inhibition of Platelet-Derived Growth Factor
  24. Proteomics and Neurodegenerative Disorders: Advancements in the Diagnostic Analysis
  25. Promising Anti-stroke Signature of Voglibose: Investigation through In- Silico Molecular Docking and Virtual Screening in In-Vivo Animal Studies
  26. Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery Systems
  27. Anticancer Potential of Mefenamic Acid Derivatives with Platelet-Derived Growth Factor Inhibitory Property
  28. Endometriotic Intramyometrial cyst –A Diagnostic Dilemma
  29. Glioblastoma under siege of Therapeutics and Research: “Advancements and Future Targets”
  30. Lyme Neuroborreliosis - The Mystifying Pitfall: “Neuropathology and Current Therapeutics”
  31. Pre and post exposure of voglibose and sexagliptin improves brain injury and cognition in MCAo induced stroke and cognitive decline
  32. A Critical Case Report-Cloacal Malformation: Prenatal Diagnosis and Autopsy Findings
  33. Delivery of Biomolecules to the Central Nervous System Using a Polysaccharide Nanocomposite
  34. Pre- and post-exposure talampanel (GYKI 53773) against kainic acid seizures in neonatal rats